Researchers assessed clinical features, muscle biopsy scores, and myositis-specific antibody profiles in juvenile dermatomyositis, and their association with disease outcomes and treatment responses in patients.
Researchers aimed to evaluate the feasibility of studying creatine in juvenile dermatomyositis and to determine the effect of creatine on muscle function and metabolism.
Study authors investigated the link between anti-P155/140 and lipodystrophy, and between anti-P155/140 and damage to the nailfold capillary system in children with juvenile dermatomyositis.
Researchers investigated the content validity of patient-reported outcome measures in patients with idiopathic inflammatory myopathies.
Researchers assessed and compared the fracture risk and prevalence of osteoporosis in patients with idiopathic inflammatory myopathy and rheumatoid arthritis.
Authors of a report presented the case of systemic sclerosis-polymyositis overlap syndrome in an adolescent with anti-Ku antibodies.
Experts highlight the need for cancer screening strategies in patients with rheumatic diseases.
Researchers determined whether a modified disease activity score (DAS) correlated with the validated DAS in patients with juvenile dermatomyositis.
Researchers studied growth and puberty in a multinational prospective cohort of children with juvenile dermatomyositis.
A triple steroid/intravenous immunoglobulin/steroid-sparing immunosuppressant induction strategy was effective for the treatment of statin-induced anti-HMGCR myopathy.